Regeneron beats Q2 estimates as Dupixent hits record $6B quarter
Plus: Wellstar Health System cuts 761 corporate jobs. The day's rules, money, and enforcement, sourced and tiered below.
Plus: Wellstar Health System cuts 761 corporate jobs. The day's rules, money, and enforcement, sourced and tiered below.
|
American Health Intel
Rules · Money · Medicine · Decoded daily
|
| The Ledger |
Sunday, August 2, 2026 |
|
|
Regeneron beats Q2 estimates as Dupixent hits record $6B quarter
|
|
Plus: Wellstar Health System cuts 761 corporate jobs. The day's rules, money, and enforcement, sourced and tiered below.
|
|
|
Earnings Confidence: High
Regeneron, the biotech behind blockbuster eczema and asthma drug Dupixent, beat Wall Street's second-quarter estimates on both revenue and profit, as Dupixent posted its biggest quarter ever.
Revenue hit $4.29 billion, up 17%. Dupixent's global sales jumped 38% to $6.0 billion, a record, while Regeneron's own EYLEA HD and Libtayo each grew more than 30% and also hit new sales highs.
|
Why it matters
Regeneron's blowout quarter shows demand for its immunology and eye drugs keeps climbing, a sign biotech innovation is still commanding premium pricing. Watch whether Dupixent's growth holds as competitors enter the eczema and asthma space.
|
|
|
Other Confidence: High
Wellstar Health System, the nonprofit hospital network that is one of Georgia's largest employers, is cutting 761 corporate and administrative jobs, about 2% of its workforce.
The cuts hit corporate and shared-services functions and some administrative roles, not frontline caregivers. Wellstar says the move follows an industry-benchmark review meant to simplify its structure and speed decision-making.
|
Why it matters
A major nonprofit hospital system trimming corporate staff signals financial pressure even at large, established health systems. Watch whether other Georgia or regional systems follow with similar restructuring.
|
|
|
Also today
Guardian Dentistry Partners acquires 38-location Select Dental Management Read
FRONTIER SCAN: Knox Lane's $437M Cross Country Healthcare buyout Read
|
364 Records | $28.6B Enforcement | 17 Deadlines | 108 Rules |
|
|
Pick your field on the site and every story tells you what it means for you.
|
|
Reply to this email and tell us what you want covered. We read everything.
|
|
We show our work. We score our own calls.
News and analysis, not legal, medical, coding, or investment advice.
You subscribed at americanhealthintel.com · Unsubscribe
|
|